PD15: Prostate Cancer: Localized: Radiation Therapy

Podium Session Moderator(s)

• 

  John Davis, MD

  Professor of Urology
  MD Anderson Cancer Center
• 

  Martha Terris, MD (she/her/hers)

  Chair
  Medical College of Georgia- Augusta University
• 

  Mack Roach, III, MD,BS

  Professor Radiation Oncvology & Urology
  UCSF

Presentations:

• 7:00 AM – 7:10 AM CST

  PD15-01: SURVIVAL IN ADJUVANT VS SALVAGE RADIATION THERAPY IN PATHOLOGICAL NODE POSITIVE PROSTATE CANCER PATIENTS: A MULTICENTRIC STUDY
  

  Podium Presenter: Francesco Chierigo, MD
• 7:10 AM – 7:20 AM CST

  PD15-02: Long-Term Health Related Quality of Life in Prostate Cancer Patients Requiring Radiotherapy After Radical Prostatectomy
  

  Podium Presenter: Peter Chang, MD – Beth Israel Deaconess Medical Center
• 7:20 AM – 7:30 AM CST

  PD15-03: Radiation dose required to control prostate cancer as determined by post-treatment biopsy: long term results
  

  Podium Presenter: Nelson N. Stone, MD (he/him/his) – Nelson N. Stone MDPC
• 7:30 AM – 7:40 AM CST

  PD15-04: Prediction of prostate cancer specific mortality in men undergoing radiotherapy with or without hormonal treatment, risk stratification based on clinical characteristics and PSA treatment response.
  

  Podium Presenter: Ugo G. Falagario, MD – University of Foggia
• 7:40 AM – 7:50 AM CST

  PD15-05: Long- term rates of biochemical recurrence after primary external beam radiation therapy for prostate cancer
  

  Podium Presenter: Domenique Escobar, MD
• 7:50 AM – 8:00 AM CST

  PD15-06: Systematic Prostate Biopsy with Insufficient Biopsy Core Number at Diagnosis Leads PSA Failure after Brachytherapy as Monotherapy for Clinical Stage T1c Prostate Cancer
  

  Podium Presenter: Yu Ozawa, MD (he/him/his) – AdventHealth Global Robotics Institute
• 8:00 AM – 8:10 AM CST

  PD15-07: Prostate brachytherapy case volume in the community setting does not affect oncologic outcomes
  

  Podium Presenter: Kevin Chang, BA (he/him/his)
• 8:10 AM – 8:20 AM CST

  PD15-08: Prostate Bed Deformations and Dosimetric Implications: An Exploratory Analysis of a Phase II Clinical Trial (SCIMITAR)
  

  Podium Presenter: Tommy Jiang, BA
• 8:20 AM – 8:30 AM CST

  PD15-09: Real world assessment of MRI predictors of rectal complications following transperineal SpaceOAR Hydrogel Insertion
  

  Podium Presenter: Jonathan Kam, MD (he/him/his) – Nepean Hospital, Sydney, Australia
• 8:30 AM – 8:40 AM CST

  PD15-10: Outcomes for Patients undergoing SpaceOAR Placement in the Salvage Radiation Therapy Setting
  

  Podium Presenter: Spencer Hampton Bell, MD – Fox Chase Cancer Center
• 8:40 AM – 8:50 AM CST

  PD15-11: EFFICACY AND SAFETY OF BIODEGRADABLE RECTAL SPACER BALLOON IN PATIENTS RECEIVING PROSTATE IMRT: AN INTERNATIONAL PHASE 3 RANDOMIZED TRIAL
  

  Podium Presenter: Daniel Song